Clinical Trial

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicentre post-marketing prospective study to evaluate performance and clinical outcomes of AMIIStem primary hip system.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2010-04-19; most recent amendment 2024-12-11.
Status change: Recruiting → Active, Not Recruiting 2018-05-02
Trial Details
NCT Number NCT01107340
Lead Sponsor Medacta International SA
Conditions Osteoarthritis, Arthritis, Avascular Necrosis, Fracture of the Femoral Neck or Head, Congenital Hip Dysplasia
Enrollment 500 participants
Start Date 2010-01
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-16